These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7131490)

  • 1. Hypobetalipoproteinemic agents. 3. Variation of the polycyclic portion of 4-(1-adamantyloxy)aniline.
    Heyd WE; Bell LT; Heystek JR; Schurr PE; Day CE
    J Med Chem; 1982 Sep; 25(9):1101-3. PubMed ID: 7131490
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypobetalipoproteinemic agents. 2. Compounds related to 4-(1-adamantyloxy)aniline.
    Lednicer D; Heyd WE; Emmert DE; TenBrink RE; Schurr PE; Day CE
    J Med Chem; 1979 Jan; 22(1):69-77. PubMed ID: 218007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of a hypobetalipoproteinemic agent.
    Day CE; Schurr PE; Heyd WE; Lednicer D
    Adv Exp Med Biol; 1976; 67(00):231-249. PubMed ID: 179296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of 2-adamantanone oxime carbamate derivatives.
    Georgiev VS; Bennett GA; Radov LA; Kamp DK; Trusso LA
    Arch Pharm (Weinheim); 1987 May; 320(5):465-70. PubMed ID: 3606351
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiviral agents. 24. 4(-2-Adamantyl)thiosemicarbazone].
    Kreutzberger A; Schröders HH; Stratmann J
    Arch Pharm (Weinheim); 1984 Sep; 317(9):767-71. PubMed ID: 6508510
    [No Abstract]   [Full Text] [Related]  

  • 6. [Synthesis of derivatives of N-(1-adamantyl)-N'-urea with potential antiviral activity].
    Skwarski D; Maliszewska H
    Acta Pol Pharm; 1988; 45(5):391-4. PubMed ID: 3247849
    [No Abstract]   [Full Text] [Related]  

  • 7. [Compounds with potential antitumor activity. II. N,N'-(1-Diadamantandicarboxyamides)].
    Ficarra P; Ficarra R; Tommasini A; Fenech G
    Farmaco Sci; 1983 Jun; 38(6):418-24. PubMed ID: 6873275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypo-beta-lipoproteinemic agents. 1. Bicyclo[2.2.2]octyloxyaniline and its derivatives.
    Day CE; Schurr PE; Emmert DE; TenBrink RE; Lednicer D
    J Med Chem; 1975 Nov; 18(11):1065-70. PubMed ID: 170403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiviral agents. 22. N-aliphatic, N-alicyclic and N-polycyclic substituted N'-(2-adamantyl)ureas and -thioureas].
    Kreutzberger A; Tantawy A
    Arzneimittelforschung; 1983; 33(4):512-4. PubMed ID: 6683528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of hypolipidemic agents. I. Syntheses and hypolipidemic activities of 1-substituted 2-alkanone derivatives.
    Ogawa K; Terada T; Muranaka Y; Hamakawa T; Hashimoto S; Fujii S
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1118-27. PubMed ID: 3731335
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on hypolipidemic agents. II. Synthesis of 1-arenesulfonyloxy-2-alkanone derivatives as potent esterase inhibitors and hypolipidemic agents.
    Ogawa K; Terada T; Muranaka Y; Hamakawa T; Hashimoto S; Fujii S
    Chem Pharm Bull (Tokyo); 1986 Aug; 34(8):3252-66. PubMed ID: 3791497
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with type 2 diabetes.
    Matikainen N; Taskinen MR
    Diabet Med; 2013 Jun; 30(6):756-7. PubMed ID: 23215876
    [No Abstract]   [Full Text] [Related]  

  • 13. (+/-)-1-(Adamantan-2-yl)-2-propanamine and other amines derived from 2-adamantanone.
    Mariani E; Schenone P; Bondavalli F; Lampa E; Marmo E
    Farmaco Sci; 1980 May; 35(5):430-40. PubMed ID: 7192647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypolipidemic activity of rifamycin derivatives.
    Traxler P; Kump W; Mueller K; Tosch W
    J Med Chem; 1990 Feb; 33(2):552-60. PubMed ID: 2299623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on hypolipidemic agents. III. Synthesis and esterase-inhibitory activity of omega-cycloalkyl-2-oxoalkyl arenesulfonates.
    Ogawa K; Terada T; Muranaka Y; Hamakawa T; Fujii S
    Chem Pharm Bull (Tokyo); 1987 Jun; 35(6):2426-36. PubMed ID: 3664839
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on hypolipidemic agents. II. 3-(4-Phenoxybenzoyl)-propionic acid derivatives.
    Tomisawa K; Kameo K; Matsunaga T; Saito S; Hosoda K; Asami Y; Sota K
    Chem Pharm Bull (Tokyo); 1985 Jun; 33(6):2386-94. PubMed ID: 4064197
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis of 5-alkyl-4-oxazoleacetic acid derivatives with hypolipidemic activities.
    Seki M; Moriya T; Matsumoto K; Takashima K; Mori T; Odawara A; Takeyama S
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4435-40. PubMed ID: 3246011
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on hypolipidemic agents. II. Synthesis and pharmacological properties of alkylpyrazole derivatives.
    Seki K; Isegawa J; Fukuda M; Ohki M
    Chem Pharm Bull (Tokyo); 1984 Apr; 32(4):1568-77. PubMed ID: 6467462
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on hypolipidemic agents. IV. Syntheses and biological activities of trans- and cis-2-(4-alkylcyclohexyl)-2-oxoethyl arenesulfonates.
    Ogawa K; Terada T; Muranaka Y; Hamakawa T; Ohta S; Okamoto M; Fujii S
    Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3276-83. PubMed ID: 3427711
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on hypolipidemic agents. I. 3-Benzoylglycidic acid derivatives.
    Tomisawa K; Kameo K; Goi M; Sota K
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):3066-74. PubMed ID: 6518588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.